Literature DB >> 6871765

Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites, and quantitative bone histology.

Y L Chan, A C Alfrey, S Posen, D Lissner, E Hills, C R Dunstan, R A Evans.   

Abstract

The effects of intraperitoneal aluminum chloride (1.5 mg aluminum/kg/day for 9 weeks) were studied in normal and uremic rats. Parameters measured included tissue aluminum, serum vitamin D metabolites, and quantitative bone histology. Aluminum administration increased tissue concentrations of this metal in uremic and nonuremic animals. Bone aluminum concentrations were higher in uremic rats (121 +/- 27 mg/kg compared to 47 +/- 4), whereas liver values were higher in the nonuremic group (175 +/- 47 mg/kg compared to 100 +/- 36). Serum concentrations of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D were reduced in uremia, but aluminum was without apparent effect on any vitamin D metabolite. Aluminum, in the doses administered, caused no skeletal changes in nonuremic animals. Some uremic, non-aluminum-treated rats developed osteomalacia and marrow fibrosis. However, osteomalacia was more severe and the osteoclast count was higher in the uremic, aluminum-treated rats. In this group of animals the mineral apposition rate was reduced at the metaphyseal endosteum but increased at the periosteum, indicating different control mechanisms at the two sites.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871765     DOI: 10.1007/bf02405056

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  31 in total

1.  A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma.

Authors:  J A Eisman; A J Hamstra; B E Kream; H F DeLuca
Journal:  Arch Biochem Biophys       Date:  1976-09       Impact factor: 4.013

2.  The relevance of 25-hydroxycalciferol measurements in sera of patients with renal failure.

Authors:  R S Mason; D Moddel; A McElduff; J H Stewart; J F Mahony; S Posen
Journal:  Aust N Z J Med       Date:  1979-06

3.  Aluminium retention and toxicity in chronic renal failure.

Authors:  H Thurston; G R Gilmore; J D Swales
Journal:  Lancet       Date:  1972-04-22       Impact factor: 79.321

4.  Measuring picogram amounts of aluminum in biological tissue by flameless atomic absorption analysis of a chelate.

Authors:  G R LeGendre; A C Alfrey
Journal:  Clin Chem       Date:  1976-01       Impact factor: 8.327

5.  Haemodialysis related osteomalacia: a staining method to demonstrate aluminium.

Authors:  M R Buchanan; B U Ihle; C M Dunn
Journal:  J Clin Pathol       Date:  1981-12       Impact factor: 3.411

6.  Aluminum related dialysis osteomalacia and dementia after prolonged use of the Redy cartridge.

Authors:  A M Pierides; P P Frohnert
Journal:  Trans Am Soc Artif Intern Organs       Date:  1981

7.  Histological quantitation of aluminum in iliac bone from patients with renal failure.

Authors:  N A Maloney; S M Ott; A C Alfrey; N L Miller; J W Coburn; D J Sherrard
Journal:  J Lab Clin Med       Date:  1982-02

8.  Dementia, renal failure, and brain aluminum.

Authors:  A I Arieff; J D Cooper; D Armstrong; V C Lazarowitz
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

9.  Reduced serum levels of 1 alpha,25-dihydroxyvitamin D during long-term total parenteral nutrition.

Authors:  G L Klein; R L Horst; A W Norman; M E Ament; E Slatopolsky; J W Coburn
Journal:  Ann Intern Med       Date:  1981-05       Impact factor: 25.391

10.  Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization.

Authors:  G Cournot-Witmer; J Zingraff; J J Plachot; F Escaig; R Lefèvre; P Boumati; A Bourdeau; M Garabédian; P Galle; R Bourdon; T Drüeke; S Balsan
Journal:  Kidney Int       Date:  1981-09       Impact factor: 10.612

View more
  15 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Induction of de novo bone formation in the beagle. A novel effect of aluminum.

Authors:  L D Quarles; H J Gitelman; M K Drezner
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

3.  In vitro model of aluminum-induced osteomalacia: inhibition of hydroxyapatite formation and growth.

Authors:  N C Blumenthal; A S Posner
Journal:  Calcif Tissue Int       Date:  1984-07       Impact factor: 4.333

4.  Impairment of bone formation with aluminum and ferric nitrilotriacetate complexes.

Authors:  Y Ebina; S Okada; S Hamazaki; Y Toda; O Midorikawa
Journal:  Calcif Tissue Int       Date:  1991-01       Impact factor: 4.333

Review 5.  [Aluminum toxicity].

Authors:  H V Henning
Journal:  Klin Wochenschr       Date:  1989-12-15

6.  Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig.

Authors:  A B Sedman; A C Alfrey; N L Miller; W G Goodman
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

7.  Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.

Authors:  C R Dunstan; R A Evans; E Hills; S Y Wong; A C Alfrey
Journal:  Calcif Tissue Int       Date:  1984-03       Impact factor: 4.333

8.  Short-term aluminum administration in the rat. Effects on bone formation and relationship to renal osteomalacia.

Authors:  W G Goodman; J Gilligan; R Horst
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

9.  Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure.

Authors:  H H Malluche; M C Faugere; R M Friedler; C Matthews; P Fanti
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

10.  The effect of metabolic acidosis on vitamin D metabolites and bone histology in uremic rats.

Authors:  Y L Chan; E Savdie; R S Mason; S Posen
Journal:  Calcif Tissue Int       Date:  1985-03       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.